Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
AdipoGen Life Sciences
MI-2 [MALT1 Inhibitor]
120
CHF
CHF 120.00
In stock
AG-CR1-3661-M0055 mgCHF 120.00
AG-CR1-3661-M02525 mgCHF 480.00
Product Details | |
---|---|
Synonyms | 2-Chloro-N-[4-[5-(3,4-dichlorophenyl)-3-(2-methoxyethoxy)-1H-1,2,4-triazol-1-yl]phenylacetamide; ALB-H03200218 |
Product Type | Chemical |
Properties | |
Formula |
C19H17Cl3N4O3 |
MW | 455.7 |
CAS | 1047953-91-2 |
Purity Chemicals | ≥98% |
Appearance | White to off-white solid. |
Solubility | Soluble in DMSO (30mg/ml) or ethanol (5mg/ml). |
InChi Key | TWJGQZBSEMDPQP-UHFFFAOYSA-N |
Smiles | COCCOC1=NN(C2=CC=C(NC(CCl)=O)C=C2)C(C3=CC=C(Cl)C(Cl)=C3)=N1 |
Shipping and Handling | |
Shipping | AMBIENT |
Short Term Storage | +4°C |
Long Term Storage | -20°C |
Handling Advice | Keep cool and dry. |
Use/Stability | Stable for at least 2 years after receipt when stored at -20°C. |
Documents | |
MSDS | Download PDF |
Product Specification Sheet | |
Datasheet | Download PDF |
Description
- Highly potent and selective irreversible MALT1 inhibitor (IC50=5.8μM). Binds directly to MALT1 and suppresses protease function.
- Decreases NF-κB activity induced by MALT1. Inhibits cell proliferation and MALT1-mediated cleavage activity. Suppresses human TMD8 and HBL-1 (EC50= ~200nM and ~500nM for HBL-1 and TMD8, respectively) activated B cell-like diffuse large B cell lymphoma (ABC-DLBCL) cell lines in vitro and xenotransplanted mouse ABC-DLBCL tumors in vivo and primary human ABC-DLBCLs ex vivo.
- In combination with bryostatin 1 displays selective killing of HIV latently infected CD4+ T cells.
- Inhibits NF-κB and NLRP3 inflammasome activation in macrophages. Decreased production of IL-1β/IL-18 in PMA-differentiated THP-1 cells and bone marrow derived macrophage via suppressing the activation of NF-κB and NLRP3 inflammasome.
Product References
- MALT1 small molecule inhibitors specifically suppress ABC-DLBCL in vitro and in vivo: L. Fontan, et al.; Cancer Cell 22, 812 (2012)
- MALT1 inhibitors prevent the development of DSS-induced experimental colitis in mice via inhibiting NF-κB and NLRP3 inflammasome activation: W. Liu, et al.; Oncotarget 7, 30536 (2016)
- Short Communication: Preferential Killing of HIV Latently Infected CD4(+) T Cells by MALT1 Inhibitor: H. Li, et al.; AIDS Res. Hum. Retroviruses 32, 174 (2016)